United Urology Group is the largest urology practice in Maryland and the Mid-Atlantic region with a national network of urology affiliates which provide the highest quality, most fully-integrated urology care available to patients. Composed of more than 150 of the top urologists, including many who are fellowship trained, radiation oncologists, pediatric urologist, and urologic pathologists. Our prostate cancer specialists understand that providing the very best care is about caring for the whole person. All of our urologists diagnose prostate cancer and many are specialists with advanced training in such areas as 3D Ultrasound/MRI Fusion Prostate Cancer Biopsy, Robotic Surgery, Radiation Therapy, Infusion Therapy, Brachytherapy, HIFU, Cryotherapy, Advanced Prostate Cancer Treatment as well as a nationally recognized Research department. Developed a nationally recognized Center of Excellance for our Provenge Program. Managing all aspects of providing patients w/ advanced cancer therapies to include Provenge ( Sipuleucel-T), Xofigo, (Radium 223) as well as oral oncolytics and bone health therapies.Utilizing PPS Analytics to identify patients for our APC therapies - Provenge, Xofigo, Zytiga, Xtandi & Clinical Trials. PPS allows me to identify earlier and navigate these patients to therapy faster. Liaison between our patients and physicians & APPs during our patients cancer journey.Creating a program where our patients/wives are matched with other patients/wives that have completed therapies so they have a sense of comfort and confidence, setting our patient as well as their families up for success for whatever therapy they're currently undergoing.Providing guidance, training and support to all our Patient Navigators across Maryland, Tennessee, Colorado & Arizona.

Provenge is an immunotherapy that takes the patient's own immune cells and reprograms them to attack his advanced prostate cancer. Provenge is the ONLY personalized treatment that is clinically proven to help extend life in men with metastatic prostate cancer. It is a joy to visit accounts to assist with the development/operationalize of their own Provenge program. Dendreon Corporation is a biotechnology company focused on targeting cancer and transforming lives through the discovery, development, commercialization, and manufacturing of novel therapeutics that may significantly improve cancer treatment options for patients. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response. Dendreon is headquartered in Seattle and has manufacturing facilities in Georgia and California.